Taconic Capital Advisors’s Biogen BIIB Stock Holding History

Taconic Capital Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-117,000	Closed	-$33.1M	–	574
2021 Q3	$33.1M	Buy	117,000 +97,000	+485%	+$31.8M	0.88%	21
2021 Q2	$6.92M	Buy	20,000 +5,000	+33%	+$1.51M	0.17%	80
2021 Q1	$4.2M	Buy	15,000 +5,000	+50%	+$1.35M	0.13%	121
2020 Q4	$2.45M	Sell	10,000 -40,000	-80%	-$10.3M	0.11%	117
2020 Q3	$14.2M	Buy	50,000 +15,000	+43%	+$4.18M	0.78%	24
2020 Q2	$9.36M	Sell	35,000 -19,500	-36%	-$5.86M	0.52%	22
2020 Q1	$17.2M	Buy	54,500 +24,500	+82%	+$7.44M	1.01%	22
2019 Q4	$8.9M	Buy	+30,000	New	+$8.32M	0.36%	26
2019 Q3	–	Sell	-35,000	Closed	-$8.19M	–	41
2019 Q2	$8.19M	Buy	+35,000	New	+$8.08M	0.5%	30
2017 Q2	–	Sell	-10,500	Closed	-$2.87M	–	31
2017 Q1	$2.87M	Sell	10,500 -15,000	-59%	-$4.24M	0.32%	21
2016 Q4	$7.23M	Buy	25,500 +15,500	+155%	+$4.59M	1%	20
2016 Q3	$3.13M	Buy	+10,000	New	+$2.96M	0.39%	25

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Taconic Capital Advisors's BIIB Position: Q4 2021 in Review

Taconic Capital Advisors sold out of Biogen (BIIB) in Q4 2021, closing a stake of 117,000 shares — an estimated $33.1M sold.

Taconic Capital Advisors first reported a position in BIIB in Q3 2016 and held it in 12 quarters. The position peaked at $33.1M in Q3 2021. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

Taconic Capital Advisors reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
Taconic Capital Advisors sold 117,000 Biogen shares in Q4 2021, an estimated $33.1M.
Taconic Capital Advisors first reported a position in Biogen in Q3 2016 and held it in 12 quarters.
Taconic Capital Advisors's Biogen position peaked at $33.1M in Q3 2021.
1,010 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Taconic Capital Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.